Advanced Biomed Inc (ADVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2025 | 06-2024 | |
| Cash Flows From Operating Activities | ||
| Net Income | -3,259 | -2,782 |
| Depreciation Amortization | 344 | 400 |
| Other Working Capital | -2,910 | 256 |
| Operating Cash Flow | $-5,825 | $-2,126 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -32 | -74 |
| Investing Cash Flow | $-32 | $-74 |
| Cash Flows From Financing Activities | ||
| Debt Repayment | -600 | N/A |
| Common Stock Issued | 5,790 | 210 |
| Other Financing Activity | 744 | 1,657 |
| Financing Cash Flow | $5,934 | $1,867 |
| Exchange Rate Effect | 218 | 319 |
| Beginning Cash Position | 2,608 | 2,622 |
| End Cash Position | 2,904 | 2,608 |
| Net Cash Flow | $296 | $-14 |
| Free Cash Flow | ||
| Operating Cash Flow | -5,825 | -2,126 |
| Capital Expenditure | -32 | -74 |
| Free Cash Flow | -5,857 | -2,200 |